Cliff Asness’s Orchestra BioMed OBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.2K Buy
+11,776
New +$56.5K ﹤0.01% 4003
2026
Q1
– Sell
-16,290
Closed -$67.6K – 3804
2025
Q4
$67.6K Sell
16,290
-822
-5% -$3.32K ﹤0.01% 3493
2025
Q3
$42.4K Buy
+17,112
New +$47.2K ﹤0.01% 3427

Other funds holding OBIO

Cliff Asness's OBIO Position: Q3 2026 in Review

Cliff Asness opened a new position in Orchestra BioMed (OBIO) in Q3 2026: 11,776 shares worth $73.2K. The stake represents ﹤0.01% of the portfolio and ranks #4003 among its holdings. This is a return to the name: Cliff Asness previously reported a position in OBIO as recently as Q4 2025.

Cliff Asness first reported a position in OBIO in Q3 2025 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.

  • Cliff Asness held 11,776 shares of Orchestra BioMed worth $73.2K as of Q3 2026.
  • Orchestra BioMed was a new Cliff Asness position in Q3 2026.
  • Orchestra BioMed made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #4003 holding.
  • Cliff Asness first reported a position in Orchestra BioMed in Q3 2025 and has held it in 3 quarters since.
  • 88 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.